You are here: Industry Insights > Vaccine

News List

Eurocine Vaccines has selected Biovian as contract developer for the chlamydia vaccine candidate prnasia
December 31, 2020
Eurocine Vaccines AB has today selected Biovian Oy, Turku, Finland, as the contract developer for the Company's vaccine candidate against chlamydia. Biovian, which is an internationally recognized contract developer and manufacturer with its own GMP ...
Serum Institute of India launches indigenously developed pneumococcal vaccine, ‘PNEUMOSIL’ expresspharma
December 29, 2020
This WHO pre-qualified PCV is specially tailored to the prevailing serotype prevalence of S. pneumoniae in India and other regions of the world.
US vaccine rollout’s next challenge: Verifying who is ‘essential’ expresspharma
December 24, 2020
The vaccination campaign under way is now focused on hospital staff and nursing homes, tightly controlled environments.
India likely to approve AstraZeneca vaccine by next week – sources expresspharma
December 23, 2020
AstraZeneca-Oxford shot is considered vital for lower-income countries and those in hot climates.
Neutralizing antibodies protect against severe COVID-19 worldpharmanews
December 21, 2020
Understanding the body's immune response to SARS-CoV-2, the virus that causes COVID-19, is key to developing effective treatments and long-lasting vaccines.
India to make 300 million Sputnik V vaccines expresspharma
December 21, 2020
India will produce about 300 million doses of Russia’s Sputnik V coronavirus vaccines next year, a Russian official was quoted as saying, nearly three times the previously known number as deals have been signed with more manufacturers.
Oxford/AstraZeneca vaccine likely to get approval by year-end in UK expresspharma
December 21, 2020
AstraZeneca has said a further 15 million doses of active ingredients are ready and can be filled into vials in a matter of days.
US CDC gives recommendations for COVID-19 inoculation after allergic reactions expresspharma
December 21, 2020
People who have had a severe allergic reaction to any ingredient in a COVID-19 vaccine should avoid the vaccine formulation containing the ingredient, CDC said.
Codagenix Completes Dosing for Trial of Live-Attenuated, Intranasal Vaccine for RSV americanpharmaceuticalreview
December 18, 2020
Codagenix announced the completion of dosing in a Phase 1 clinical trial of its live attenuated CodaVax™-RSV vaccine, an intranasally-administered vaccine for the prevention of respiratory syncytial virus (RSV).
Many people may not receive a COVID-19 vaccine until 2022 europeanpharmaceuticalreview
December 17, 2020
Studies show that more than a fifth of the global population, mostly in low- and middle-income countries, may have to wait until at least 2022 to receive a COVID-19 vaccine.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page